Executives from both Europe and the United States face the same question: Where is there still space for foreign companies in China, and what does “winning” realistically look like? Below is an executive summary of the expert webinar “Localize or Lose” with Sinolytics Senior Consultant Bowen Han, including key themes, strategic implications, and a curated Q&A capturing the most critical questions from your peers.
The webinar emphasized an important principle: China’s five‑year plans are high‑level, strategic documents — not operational details. They set intent, priorities, and the direction of policy tools to follow. And historically, when something appears in a five‑year plan, Beijing follows through.
Even subtle wording changes can indicate future shifts in budget allocation, regulatory pressure, or market access conditions.
The keyword analysis presented in the webinar highlighted three major developments:
Mentions of “stability” rose sharply, marking China’s transition from quantity‑driven growth to quality‑driven economic management. This reduces pressure on local governments to pursue unsustainable investments, which may lead to more rational industrial policies.
Terms related to AI, tech innovation, and green development surged. China is moving into a cycle where technology self‑sufficiency defines national competitiveness, geopolitical leverage, and future industrial leadership.
The biggest leap in attention: Employment, consumption, and livelihood. China is signalling a long‑term shift from investment‑driven growth to domestic consumption–driven growth, a transformation that could reshape demand patterns across industries. Notably, Beijing intentionally avoided setting a hard consumption‑to‑GDP target — leaving space for flexibility amid geopolitical uncertainty.
While most parts of the plan remain strategic and intentionally vague, localization is not. Beijing outlines specific, actionable, measurable steps related to:
For foreign companies, this means: Localization pressure will not only increase — it will become more formalized, more measurable, and more enforceable.
Starting January 2026, China introduced a long‑awaited definition of “domestic products”, initially for public procurement but intended to shape broader market behavior.
The key mechanism:
A product will be considered “Made in China” if the cost share of components produced in China exceeds a threshold that Beijing will define sector‑by‑sector. Foreign companies meeting the threshold will enjoy a 20% price advantage in government bidding evaluations — a major incentive to localize.
But there are three strategic caveats:
Foreign companies need to prepare for a multi‑tier supply chain localization challenge, not just final assembly.
The webinar offered a practical decision framework based on two dimensions: your R&D approach and your industry’s strategic sensitivity.
China offers world‑class engineering talent, strong universities, competitive R&D costs, and growing incentives for cross‑border innovation partnerships.
For industries like healthcare, life sciences, AI, and green technologies, China’s innovation ecosystem can become a strategic advantage, not just a cost center.
If you operate in sectors deemed “national security relevant” (e.g., semiconductors, cybersecurity, defense‑adjacent technologies), heavy localization may create a dead‑end scenario:
In such sectors, the government ultimately wants a Chinese champion on top.
China often welcomes foreign firms early to stimulate local industrial upgrading. But over time, as domestic competitors strengthen, foreign companies may be:
The strategic question for executives: Where are we in this lifecycle — and what is our desired endgame?
Will the domestic product rules expand from public procurement to the private sector?
Probably — but gradually. Public procurement acts as a “testing ground.” If implementation is smooth, private‑sector spillover is likely, especially informally.
Is this protectionism?
Yes and no. It formalizes rules that were previously informal — and sometimes far more restrictive at the local level. Clear rules may actually reduce arbitrary protectionism.
How can companies keep up with operational policy changes, especially in highly regulated sectors like life sciences?
Real‑time, multi‑ministry policy monitoring is essential. Most major regulatory shifts are preceded by signals in five‑year plans, industry plans, and action plans.
How can foreign firms avoid the “endgame scenario” of being pushed out?
Avoid deep localization in sectors with no long‑term space for foreign leadership. Prioritize niches where you can defend a sustainable share — and where localization creates strategic value rather than strategic exposure.
How do we make the case against “just exit China” narratives in Europe and the U.S.?
Because even a single‑digit market share in China can be economically meaningful. And because Chinese competition is global — understanding it up close is a strategic advantage.
Will export controls expand beyond rare earths?
Signals point to yes — especially in industries Beijing considers strategic or security‑sensitive. Companies should map Tier‑X suppliers and prepare for deeper transparency demands.
China's 15th Five‑Year Plan marks the beginning of a new chapter: Foreign companies are still welcome — but only on China’s terms. Executives need to answer three strategic questions:
Those who act early, monitor policy closely, and localize with clear intent will not only survive, but may find new competitive advantages in the world’s most complex major market.
🎥 Full Webinar Recording
